West Pharmaceutical Services, Inc.
Financials
Valuation Metrics
West Pharmaceutical Services, Inc.'s Market Cap is $28.82B. At end of 2025 it was $19.87B. Ranked #463 of 3,118 in US market (top 15%), #330 of 1,644 on NYSE (top 20%), #33 of 203 in Health Care Equipment & Services (top 16%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $28.82B | US#463/3,118 Sec#33/203 |
| Revenue | $3.40B | US#1,126/3,118 Sec#69/203 |
| Net Income | $639M | US#779/3,118 Sec#45/203 |
| Total Assets | $4.06B | US#1,576/3,118 Sec#74/203 |
| Net Assets | $2.97B | US#970/3,118 Sec#50/203 |
| Employees | 10,800 | US#824/3,118 Sec#67/203 |
| Value | ||
| P/E | 45.10x | US#1,921/3,118 Sec#99/203 |
| P/B | 9.71x | US#2,610/3,118 Sec#167/203 |
| PEG | 1.51x | US#1,131/3,118 Sec#58/203 |
| P/S | 8.48x | US#2,649/3,118 Sec#177/203 |
| EV/EBITDA | 29.64x | US#2,279/3,118 Sec#122/203 |
| FCF Yield | 1.57% | US#2,098/3,118 Sec#127/203 |
| Profitability | ||
| ROE | 21.52% | US#652/3,118 Sec#30/203 |
| ROA | 15.73% | US#265/3,118 Sec#15/203 |
| Op. Margin | 22.97% | US#860/3,118 Sec#28/203 |
| Revenue Growth | 12.58% | US#1,064/3,118 Sec#72/203 |
| Earnings Growth | 29.94% | US#930/3,118 Sec#51/203 |
| Financial Health | ||
| Debt Ratio | 36.81% | US#415/3,118 Sec#43/203 |
| Total Debt | $305M | US#2,075/3,118 Sec#112/203 |
| FCF | $453M | US#956/3,118 Sec#55/203 |
| Cash | $464M | US#1,156/3,118 Sec#68/203 |
| Current Ratio | 2.82x | US#840/3,118 Sec#86/203 |
| Net Debt/EBITDA | -0.16x | US#511/3,118 Sec#41/203 |
| Dividend | ||
| Div. Yield | 0.22% | US#1,641/3,118 Sec#51/203 |
| Div. Growth | 4.56% | US#844/3,118 Sec#30/203 |
| Performance | ||
| 1Y Return | 44.85% | US#514/3,118 Sec#52/203 |
| 1M Return | 11.76% | US#683/3,118 Sec#53/203 |
| From 52W High | -6.93% | US#493/3,118 Sec#46/203 |
| 1Y MDD | -19.38% | US#586/3,118 Sec#15/203 |
| Trading | ||
| Volume | 1,233,236 shares | US#1,663/3,118 Sec#114/203 |
| Trading Value | $507M | US#343/3,118 Sec#33/203 |
| Per Share | ||
| EPS | $9.04 | US#397/3,118 Sec#28/203 |
| BPS | $42.01 | US#571/3,118 Sec#40/203 |
Company Info
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.